NCT06500273 Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL Status RECRUITING Phase PHASE2
NCT04093596 Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) Status COMPLETED Phase PHASE1